Invention Grant
- Patent Title: Mucin antigen vaccine
- Patent Title (中): 粘蛋白抗原疫苗
-
Application No.: US13662616Application Date: 2012-10-29
-
Publication No.: US08501707B2Publication Date: 2013-08-06
- Inventor: Yucheng Tang , Albert Deisseroth
- Applicant: MicroVAX, LLC
- Applicant Address: US VA Manassas
- Assignee: MicroVAX, LLC
- Current Assignee: MicroVAX, LLC
- Current Assignee Address: US VA Manassas
- Agent Jacob Frank; Glenn Snyder
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K39/00 ; A61K39/12

Abstract:
Provided are expression vectors for generating an immune response to a mucin. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal, a mucin antigen and CD40 ligand. Also provided are methods of generating an immune response against cells expressing a mucin by administering an effective amount of the vector. Further provided are methods of generating an immune response against cancer cells expressing a mucin in an individual by administering an effective amount of the vector. Still further provided are methods of overcoming anergy to a mucin self antigen by administering an effective amount of the vector.
Public/Granted literature
- US20130101626A1 MUCIN ANTIGEN VACCINE Public/Granted day:2013-04-25
Information query